Oral Urinary Tract Infection Treatments
Oral antibiotics for urinary tract infections (UTIs) treatment chart including dosing and duration.
Oral antibiotics for urinary tract infections (UTIs) treatment chart including dosing and duration.
Researchers assessed whether there is an association between urinary tract infection incidence and international travel.
Women with rUTIs have a gut microbiome that is significantly depleted in microbial richness and butyrate-producing bacteria.
In this meta-analysis, researchers assessed whether patient race is a proxy for other factors in predictive models that show an association between race and urinary tract infection risk.
The approvals were based on data from pediatric trials evaluating treatment for complicated intra-abdominal infections and complicated urinary tract infections.
The variable race is associated with UTI in children, but it can be replaced with history of UTI and duration of fever in a previously developed prediction tool.
As of April 5, 2022, CDC Nowcast data reported that the BA.2 subvariant accounted for more than 50% of cases in all US states and territories.
Tebipenem pivoxil hydrobromide is an orally bioavailable carbapenem with activity against uropathogenic Enterobacterales.
The phase 3 CERTAIN-1 study compared the efficacy and safety of cefepime-taniborbactam to meropenem in 661 adults with cUTI.
MV140 is a sublingual vaccine of whole-cell inactivated bacteria that may be an alternative to frequent antibiotics for recurrent urinary tract infections.